Antares Pharma Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly and | Outperform |
16
|
$771.12 | Buy/Sell | $636.99 | 13.80% | 9 | $694.32B |
| ABBV | AbbVie | Outperform |
9
|
$164.35 | Buy/Sell | $178.42 | 9.52% | 11 | $290.22B |
| PFE | Pfizer | Outperform |
2
|
$28.92 | Buy/Sell | $32.87 | 5.46% | 6 | $163.88B |
| GSK | GSK | Outperform |
12
|
£17.84 | Buy/Sell | £17.30 | 11.83% | 12 | £72.73B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.11 | Buy/Sell | $58.15 | 22.42% | 10 | $89.42B |
| CVS | CVS Health | Outperform |
12
|
$57.52 | Buy/Sell | $89.54 | 14.74% | 4 | $72.21B |
| SUNPHARMA | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.54k | Buy/Sell | Rp1.52k | 3.17% | 25 | Rp3.69T |
| WST | West Pharmaceutical Services | Outperform |
18
|
$354.11 | Buy/Sell | $380.80 | 11.55% | 2 | $25.79B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.30 | Buy/Sell | $11.59 | 4.29% | 9 | $18.46B |
| VTRS | Viatris Inc | Hold |
8
|
$11.02 | Buy/Sell | $11.73 | 8.89% | 5 | $13.32B |
| 4183 | Mitsui Chemicals | Outperform |
18
|
¥3.99k | Buy/Sell | ¥4.62k | 27.98% | 0 | ¥837.19B |
| YPSN | Ypsomed Holding | Outperform |
18
|
CHF333.50 | Buy/Sell | CHF330.00 | -1.05% | 1 | CHF4.53B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$30.10 | Buy/Sell | $44.75 | 32.89% | 0 | $4.19B |
| ALCJ | Crossject Société Anonyme | Buy |
9
|
1.97€ | Buy/Sell | 7.10€ | 153.81% | 0 | 78.33€M |
| MDP | Medexus Pharmaceuticals | Outperform |
0
|
C$1.62 | Buy/Sell | C$4.08 | 85.19% | 1 | C$45.49M |